35.84
price down icon0.69%   -0.40
 
loading
전일 마감가:
$36.24
열려 있는:
$36.435
하루 거래량:
4.24M
Relative Volume:
1.06
시가총액:
$15.46B
수익:
$2.31B
순이익/손실:
$1.66B
주가수익비율:
15.58
EPS:
2.3
순현금흐름:
$827.02M
1주 성능:
+0.36%
1개월 성능:
-1.51%
6개월 성능:
+5.99%
1년 성능:
+29.09%
1일 변동 폭
Value
$35.42
$36.44
1주일 범위
Value
$35.31
$36.70
52주 변동 폭
Value
$24.05
$38.00

로열티 파마 Stock (RPRX) Company Profile

Name
명칭
Royalty Pharma Plc
Name
전화
(212) 883-0200
Name
주소
110 EAST 59TH STREET, NEW YORK, NY
Name
직원
99
Name
트위터
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
RPRX's Discussions on Twitter

RPRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RPRX
Royalty Pharma Plc
35.77 15.67B 2.31B 1.66B 827.02M 2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
384.75 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
576.84 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
458.37 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
729.76 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
329.84 36.14B 3.81B -644.79M -669.77M -6.24

로열티 파마 Stock (RPRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-16 개시 Morgan Stanley Overweight
2024-06-03 다운그레이드 UBS Buy → Neutral
2022-06-14 재개 UBS Buy
2022-05-13 개시 Scotiabank Sector Outperform
2022-04-27 개시 Goldman Buy
2022-04-14 업그레이드 JP Morgan Neutral → Overweight
2022-04-06 재개 Morgan Stanley Overweight
2021-10-29 업그레이드 Citigroup Neutral → Buy
2021-07-30 개시 Tigress Financial Buy
2020-11-09 업그레이드 UBS Neutral → Buy
2020-07-14 개시 Evercore ISI In-line
2020-07-13 개시 BofA Securities Buy
2020-07-13 개시 Citigroup Neutral
2020-07-13 개시 Cowen Outperform
2020-07-13 개시 Goldman Neutral
2020-07-13 개시 JP Morgan Neutral
2020-07-13 개시 Morgan Stanley Equal-Weight
2020-07-13 개시 SunTrust Buy
2020-07-13 개시 UBS Neutral
모두보기

로열티 파마 주식(RPRX)의 최신 뉴스

pulisher
07:21 AM

Ruffer LLP Makes New $6.41 Million Investment in Royalty Pharma PLC $RPRX - MarketBeat

07:21 AM
pulisher
Sep 23, 2025

Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth - Yahoo Finance

Sep 23, 2025
pulisher
Sep 23, 2025

Wedge Capital Management L L P NC Grows Position in Royalty Pharma PLC $RPRX - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Royalty Pharma at Bernstein Forum: Strategic Insights on Growth By Investing.com - Investing.com UK

Sep 23, 2025
pulisher
Sep 23, 2025

Transcript : Royalty Pharma plc Presents at Bernstein Insights - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Mn Services Vermogensbeheer B.V. Acquires Shares of 67,000 Royalty Pharma PLC $RPRX - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood? - MSN

Sep 22, 2025
pulisher
Sep 22, 2025

Ridgewood Investments LLC Sells 11,236 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 22, 2025
pulisher
Sep 20, 2025

Strs Ohio Invests $1.89 Million in Royalty Pharma PLC $RPRX - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Pacific Capital Partners Ltd Sells 77,500 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Sell Signal: Does HAIN align with a passive investing strategyPortfolio Gains Report & Fast Momentum Entry Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Analyst Downgrade: Why is Royalty Pharma plc stock going downJuly 2025 Trends & AI Enhanced Trading Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today - Sahm

Sep 19, 2025
pulisher
Sep 19, 2025

Understanding Royalty Pharma plc’s price movementJuly 2025 Trends & Short-Term Swing Trade Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum - The Manila Times

Sep 19, 2025
pulisher
Sep 19, 2025

Leading Biopharma Royalty Investor Royalty Pharma Featured at Bernstein Healthcare Forum 2025 - Stock Titan

Sep 19, 2025
pulisher
Sep 19, 2025

Layoff Watch: Will Royalty Pharma plc benefit from rate cutsWeekly Trend Recap & Stock Market Timing Techniques - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 226,048 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Market Outlook: Should I buy Royalty Pharma plc stock now2025 Market Overview & Daily Entry Point Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Royalty Pharma (NASDAQ:RPRX) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Nasdaq Moves: What are the analyst revisions for GCLWWIs Royalty Pharma plc stock a good investment in YEARJuly 2025 Macro Moves & Verified Chart Pattern Trade Signals - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Royalty Pharma’s $2 Billion Debt Offering Could Be a Game Changer for RPRX - simplywall.st

Sep 17, 2025
pulisher
Sep 17, 2025

TD Cowen Maintains a Buy on Royalty Pharma (RPRX) - Insider Monkey

Sep 17, 2025
pulisher
Sep 17, 2025

Royalty Pharma Plc Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo

Sep 17, 2025
pulisher
Sep 17, 2025

Syndax, Royalty Pharma enter into $350M royalty funding deal - MSN

Sep 17, 2025
pulisher
Sep 17, 2025

12 Affordable Biotech Stocks to Invest In Now - Insider Monkey

Sep 17, 2025
pulisher
Sep 16, 2025

Empowered Funds LLC Buys New Shares in Royalty Pharma PLC $RPRX - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Royalty Pharma Completes $2 Billion Senior Notes Offering - TipRanks

Sep 16, 2025
pulisher
Sep 16, 2025

Royalty pharma to buy its external manager, announces $3B share buyback - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Royalty Pharma stock price target raised to $38 from $37 at UBS - Investing.com Nigeria

Sep 16, 2025
pulisher
Sep 16, 2025

Gainers Report: Will Royalty Pharma plc outperform the market in YEARMarket Sentiment Summary & Stock Timing and Entry Methods - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Street Watch: Does Santech Holdings Limited Depositary Receipt offer margin of safetyGlobal Markets & Fast Gain Swing Trade Alerts - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Royalty Pharma (RPRX) PT Raised to $38 at UBS, But Firm on Sidelines Due to Structural Issues - StreetInsider

Sep 16, 2025
pulisher
Sep 16, 2025

Royalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 Receipts - Yahoo Finance

Sep 16, 2025
pulisher
Sep 16, 2025

Royalty Pharma Plc's (NASDAQ:RPRX) Prospects Need A Boost To Lift Shares - 富途牛牛

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Chart Watch: Is Royalty Pharma plc stock technically oversoldTrade Risk Assessment & Community Verified Trade Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Petrus Trust Company LTA Takes Position in Royalty Pharma PLC $RPRX - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Q2 Earnings Roundup: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Segment - Yahoo Finance

Sep 16, 2025
pulisher
Sep 15, 2025

Signal Recap: Will Royalty Pharma plc be affected by tariffs2025 Earnings Surprises & AI Powered Market Entry Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

USS Investment Management Ltd Sells 42,500 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

EP Wealth Advisors LLC Takes Position in Royalty Pharma PLC $RPRX - MarketBeat

Sep 15, 2025
pulisher
Sep 13, 2025

Royalty Pharma (RPRX): Evaluating Valuation After $2 Billion Debt Offering and New Capital Moves - Sahm

Sep 13, 2025
pulisher
Sep 13, 2025

Uniplan Investment Counsel Inc. Purchases 11,904 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Sep 13, 2025
pulisher
Sep 12, 2025

Royalty Pharma PLC $RPRX Stake Lessened by Baird Financial Group Inc. - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

TD Cowen reiterates Buy rating on Royalty Pharma stock, citing strong metrics - Investing.com Nigeria

Sep 12, 2025
pulisher
Sep 12, 2025

Royalty Pharma: Investor Day Upside (NASDAQ:RPRX) - Seeking Alpha

Sep 12, 2025
pulisher
Sep 12, 2025

TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX) - StreetInsider

Sep 12, 2025

로열티 파마 (RPRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$84.16
price down icon 0.45%
$29.45
price up icon 2.51%
$99.75
price up icon 1.51%
$141.00
price down icon 3.01%
biotechnology ONC
$329.84
price down icon 0.29%
자본화:     |  볼륨(24시간):